| Hint | Answer | % Correct | |
|---|---|---|---|
| Loop Diuretic | Blocks NKCC in TALHypokalaemia Venodilation Uric Acid Retention Ca + Mg Excretion | Furosemide | 83%
|
| Potassium Sparring Diuretic | Inhibits Aldosteronevia carenone salt AldR competition | Spironolactone | 58%
|
| Calcium Channel Blocker | Dihydropyridine | Amlodipine | 42%
|
| AT1R Inhibitor | Prevents Angiotensin 2 action | Losartan | 42%
|
| ACE inhibitor | ↑Bradykinin (inflam+pain) so use AIIR inhib instead | Ramipril | 42%
|
| Factor Xa Inhibitor | Apixaban | 33%
| |
| Calcium Channel Blocker | Benzothiazepine | Diltiazem | 33%
|
| Osmotic Diuretic | Treat Cerebral Oedema (no BBB crossing) | Mannitol | 33%
|
| Calcium Channel Blocker | Phenylalkylamine | Verapamil | 33%
|
| Thrombin Inhibitor | Prevents synth of Factors 2,7,9,10Interacts with food a lot | Warfarin | 33%
|
| Renin Inhibitor | Aliskiren | 25%
| |
| Class II Dysrhythmic | beta1 adrenoceptor antagonist | Atenolol | 25%
|
| Thiazide Diuretic | Blocks Na-Cl Cotransport in DCTHypokalaemia Uric Acid retention Ca + Mg Excretion Increases blood glucose | Bendroflumethiazide | 25%
|
| SGLT Inhibitor | Lowers blood glucose as well | Dapagliflozin | 25%
|
| NCX Inhibitor | Cardiac Glycoside | Digoxin | 25%
|
| b1 AR Agonist | Increase CO but increases O2 demandUse antagonist to reduce adrenergic toxicity | Dobutamine | 25%
|
| Class Ic Dysrhythmic | Slow, no AP effects | Flecainide | 25%
|
| Thrombin Inhibitor | Activates antiThrombin IIICauses thrombocytopenia | Heparin | 25%
|
| Local Anaesthetic | Use dependence | Lidocaine | 25%
|
| Gp IIb/IIIa inhibitor | Abciximab | 17%
| |
| Carbonic Anhydrase Inhibitor | vs Glaucoma + altitude sickness | Acetazolamide | 17%
|
| Potassium Sparring Diuretic | Inhibits ENaC in DCT | Amiloride | 17%
|
| Class III Dysrhythmic | Inhibits inwards Na + outwards Kprolongs AP and refractory period | Amiodarone | 17%
|
| Thrombin Inhibitor | Reduce HIT | Argatroban | 17%
|
| Local Anaesthetic | pKA 2.6 (99% unprotonated at normal pH) | Benzocaine | 17%
|
| Thrombin Inhibitor | Leech Saliva homologue | Bivalirudin | 17%
|
| ADP-Platelet Receptor Inhibitor | Ineffective vs homozygous CYP2C19 mutations | Clopidogrel | 17%
|
| Thrombin Inhibitor | Treat A-Fib, use prophylactically for surgery | Dabigatran | 17%
|
| Calcium Sensitiser | Increases binding to Troponin. Inhibits PDE | Levosimendan | 17%
|
| Class Ib Dysrhythmic | Fast, shortens AP | Lidocaine | 17%
|
| Activates Plasminogen Activator | From Streptomycin | Streptokinase | 17%
|
| Gp IIb/IIIa Inhibitor | Prevents Fibrin and vWF binding | Tirofiban | 17%
|
| Plasminogen Inhibitor | Tranexamic Acid | 17%
| |
| Class IV Dysrythmic | L-Type calcium channel blocker | Verapamil | 17%
|
| Activates Plasminogen | TIssue plasminogen activator made from recombinant DNA | Altepase | 8%
|
| Slow release anti-clot | Plasminogen + anisoylated streptokinase | Anistreplase | 8%
|
| VGNaC Toxin | Prevents inactivation of NaC | Batrachotoxin | 8%
|
| Low Weight Heparin | Reduce HIT | Danaparoid | 8%
|
| NCX Inhibitor | Cardiac Glycoside | Ouabain | 8%
|
| Class Ia Dysrhythmic | Medium duration, lengthens AP | Quinidine | 8%
|
| K-ATP antagonist | ATP Analogue | Sulphonylurea | 8%
|
| Local Anaesthetic | pKA 8.5 (less effective at lower pH) | Tetracaine | 8%
|
| VGNaC Toxin | Binds Glu on S6 Domain IV | Tetrodotoxin | 8%
|
| Non-Diuretic Thiazide | Opens K-ATP for more InsulinVasodilator | Diazoxide | 0%
|